None listed
Conditions
Brief summary
Computer-aided polyp detection tools (CADe), utilizing artificial intelligence (AI) may increase polyp detection in the bowel during colonoscopy. Polyps are the outgrowths in the bowel that may go on the turn to colon cancer. Detecting and removing polyps is the best known method to prevent colon cancer. The primary role of these tools is the automated detection of polyps, indicating the presence and location of lesions in real time. By drawing the endoscopist’s attention to AI-recognised polyps, the software provides visual support and an additional safety mechanism that may help reduce the frequency of overlooked polyps. We aim to perform a true prospective randomised control trial to establish if AI assisted colonoscopy does increase detection as compared to our usual standard of care.
Interventions
Usual standard of care from the endoscopist doctor, with addition of Endo-AID (Olympus Corporation) AI module to be on during withdrawal phase of colonoscopy.
-Usual standard of care: single colonoscopy, which may take between 3-30 minutes. During withdrawal phase, which may take between 6 and 60 minutes, the AI module will be activated. It is not known if use of this module will increase the withdrawal time (compared to standard of care, without it).
-The nurses will advise the doctor of th
Usual standard of care from the endoscopist doctor, with addition of Endo-AID (Olympus Corporation) AI module to be on during withdrawal phase of colonoscopy. -Usual standard of care: single colonoscopy, which may take between 3-30 minutes. During withdrawal phase, which may take between 6 and 60 minutes, the AI module will be activated. It is not known if use of this module will increase the withdrawal time (compared to standard of care, without it). -The nurses will advise the doctor of the randomisation (AI or standard of care), and turn on the AI device once withdrawal has commenced. -The AI will analyse the video output from the scope to automatically detect suspected polyps in real-time during withdrawal. Polyps would then be further analysed and resected as per usual standard of care.
Sponsors
Waitakere Hospital
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Aged 18 years old or above; • They require elective colonoscopy for colorectal cancer screening, surveillance, or investigation of symptoms • Written informed consent obtained.
Exclusion criteria
• Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, significant bleeding tendency, uninterrupted anticoagulation) • Scheduled staged procedure for polypectomy or biopsy • Inflammatory Bowel Disease • Previous bowel resection • Unable to obtain informed consent
Outcome results
None listed